Bio-Path Holdings Files 8-K on Operations and Financials
Ticker: BPTH · Form: 8-K · Filed: Mar 8, 2024 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings Inc (BPTH) |
| Form Type | 8-K |
| Filed Date | Mar 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
Related Tickers: BPTH
TL;DR
BPTH filed an 8-K updating financials - check for operational details.
AI Summary
Bio-Path Holdings, Inc. filed an 8-K on March 8, 2024, reporting on its results of operations and financial condition, as well as presenting financial statements and exhibits. The filing details the company's operational and financial status without specifying any new material events or transactions.
Why It Matters
This filing provides an update on Bio-Path Holdings' financial health and operational performance, which is crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing providing an update on financial condition and operations, not announcing a major event or change.
Key Players & Entities
- BIO-PATH HOLDINGS, INC. (company) — Registrant
- 0001558370-24-002780 (filing_id) — Accession Number
- March 8, 2024 (date) — Report Date
- Delaware (jurisdiction) — State of Incorporation
- 77401 (zip_code) — Business Address Zip Code
- 832-742-1357 (phone_number) — Business Phone Number
FAQ
What is the primary purpose of this 8-K filing for Bio-Path Holdings, Inc.?
The primary purpose of this 8-K filing is to report on the company's results of operations and financial condition, and to present financial statements and exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on March 8, 2024.
In which state is Bio-Path Holdings, Inc. incorporated?
Bio-Path Holdings, Inc. is incorporated in Delaware.
What is the principal executive office address for Bio-Path Holdings, Inc.?
The principal executive office address is 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401.
Does this filing announce any specific new material events or transactions?
This filing primarily serves to update on results of operations and financial condition and present financial statements and exhibits; it does not specify any new material events or transactions.
Filing Stats: 550 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-03-08 07:10:34
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital M
Filing Documents
- bpth-20240308x8k.htm (8-K) — 38KB
- bpth-20240308xex99d1.htm (EX-99.1) — 23KB
- bpth-20240308xex99d1001.jpg (GRAPHIC) — 13KB
- 0001558370-24-002780.txt ( ) — 202KB
- bpth-20240308.xsd (EX-101.SCH) — 3KB
- bpth-20240308_lab.xml (EX-101.LAB) — 16KB
- bpth-20240308_pre.xml (EX-101.PRE) — 10KB
- bpth-20240308x8k_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. The information in this Current Report on Form 8-K (this "Current Report") is being furnished pursuant to Item 2.02 of Form 8-K and, according to general instruction B.2. thereunder, the information in this Current Report shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report shall not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended. On March 8, 2024, Bio-Path Holdings, Inc. (the "Company") issued a press release announcing financial results for the year ended December 31, 2023. Additional information is included in the Company's press release. A copy of the Company's press release is attached hereto as Exhibit 99.1. The foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press Release dated March 8, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL (included as Exhibit 101).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: March 8, 2024 By: /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer